Boditech Med Inc. (KOSDAQ:206640)
11,530
+320 (2.85%)
May 14, 2026, 3:30 PM KST
Boditech Med Market Cap
Boditech Med has a market cap or net worth of 234.58 billion as of May 14, 2026. Its market cap has decreased by -35.35% in one year.
Market Cap
234.58B
Enterprise Value
227.50B
Revenue
162.09B
Ranking
n/a
PE Ratio
10.57
Stock Price
11,530.00
Market Cap Chart
Since September 1, 2015, Boditech Med's market cap has increased from 28.15B to 234.58B, an increase of 733.26%. That is a compound annual growth rate of 21.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 228.07B | -20.20% |
| Dec 30, 2025 | 285.80B | -22.50% |
| Dec 30, 2024 | 368.76B | -18.12% |
| Dec 28, 2023 | 450.36B | 100.01% |
| Dec 29, 2022 | 225.17B | -41.09% |
| Dec 30, 2021 | 382.21B | -29.94% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BNC KOREA | 244.51B |
| HLB Pharmaceutical | 225.80B |
| CMG Pharmaceutical | 223.69B |
| Chong Kun Dang Holdings | 221.13B |
| Samjin Pharmaceuticals | 219.41B |
| Hyundai Pharmaceutical | 217.27B |
| Whan In Pharm | 211.09B |
| Daewon Pharmaceutical | 209.19B |